Outcomes of surgical treatment for active infective endocarditis under COVID-19 pandemic

XinPei Liu1, Qi Miao2, XingRong Liu1

  • 1Department of Cardiac Surgery, Peking Union Medical College Hospital, Dongcheng District, Beijing, China.

Journal of Cardiac Surgery
|February 26, 2022
PubMed

Insights

The COVID-19 pandemic impacted infective endocarditis (IE) diagnosis and treatment, leading to more emergency admissions and severe conditions. However, multidisciplinary teams maintained comparable early surgical outcomes for IE patients.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Surgical Treatment

Background:

  • The COVID-19 pandemic presented significant challenges to global healthcare systems.
  • Surgical treatment for active infective endocarditis (IE) requires careful management, potentially disrupted by pandemic-related issues.

Purpose of the Study:

  • To analyze the impact of the COVID-19 pandemic on the diagnosis, timing, and prognosis of surgical treatment for active IE.
  • To share strategies for managing IE surgical care during the pandemic.

Main Methods:

  • Retrospective analysis of 39 patients admitted for active IE in 2020 (pandemic year) compared to 50 patients from the previous year.
  • Data extracted from a surgical database, comparing patient demographics, clinical presentation, surgical risk, and outcomes.

Main Results:

  • Fewer transferred patients admitted (64.1% vs. 80%), prolonged diagnosis times (60 vs. 34.5 days), and increased emergency admissions (41% vs. 20%).
  • Higher incidence of heart failure (74.4% vs. 40%), sepsis (69.2% vs. 42.0%), and cardiogenic shock (25.6% vs. 8.0%) during the pandemic.
  • Increased surgical risk (EuroSCORE II: 4.15% vs. 3.24%), yet no significant increase in postoperative complications or early mortality (0% vs. 4%).

Conclusions:

  • The COVID-19 pandemic had multifaceted negative impacts on the clinical practice of surgical IE treatment.
  • Effective multidisciplinary IE surgical teams ensured that early outcomes remained comparable to pre-pandemic levels.
Abstract

Related Concept Videos

Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
32
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
62
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
35
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
48
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
27
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
46